This inventor holds 1 USPTO granted patent. Top assignees: Mitsubishi Tanabe Pharma Corporation, Osaka University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2023
Title: Kazufumi Otsuki: Innovator in Lysophosphatidic Acid Derivatives
Introduction
Kazufumi Otsuki is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on lysophosphatidic acid derivatives. His research focuses on developing compounds that can act as specific agonists for LPA4 receptors, which are crucial in various medical applications.
Latest Patents
Otsuki holds a patent for a novel lysophosphatidic acid derivative. This invention aims to provide a compound that acts as a specific agonist for LPA4 receptors. The pharmaceutical composition containing this compound is intended for the prophylaxis and treatment of diseases associated with angiogenesis abnormalities and vascular disorders. His patent is a significant advancement in the field, addressing critical health issues related to LPA4 receptors.
Career Highlights
Throughout his career, Kazufumi Otsuki has worked with prominent organizations, including Mitsubishi Tanabe Pharma Corporation and Osaka University. His experience in these institutions has allowed him to collaborate with leading experts in the pharmaceutical industry and academia, further enhancing his research capabilities.
Collaborations
Otsuki has collaborated with notable colleagues, including Maiko Hamada and Yuki Arai. These partnerships have contributed to the development of his innovative ideas and the successful execution of his research projects.
Conclusion
Kazufumi Otsuki's work in the field of lysophosphatidic acid derivatives showcases his dedication to advancing medical science. His innovative patent and collaborations highlight his significant impact on pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile